Kite Pharma ($KITE) has teamed up with GE Global Research ($GE) to develop an automated production system for engineered T cell therapies. The development of such a system could help Kite control the cost of manufacturing its closely-watched autologous immuno-oncology drugs. Dendreon, a pioneer in autologous cancer treatment, was dogged by high manufacturing costs throughout its attempt to make its cancer vaccine Provenge a success. Release
> Complete Genomics revealed its reorganization will result in the loss of 186 jobs. Piece (reg. req.)
> FDA scientists reviewed an algorithm designed to align NGS data to reference genomes. Article
> Parexel ($PRXL) introduced a Impact Express, a CTMS pitched at small to mid-sized drug developers. Item
> Korean CRO C&R Research adopted Medidata Clinical Cloud. Release
> Innovate UK awarded Analytics Engines and Almac a grant to develop a bioinformatics platform. More
> FactBio set up shop to develop its Kusp knowledge management platform. News
> Veeva Systems unveiled software to support the identification of key opinion leaders. Post | More